Evidence map›Paper›PMID 22634619›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.

Irina G Luzina, Edward M Pickering, Pavel Kopach, Phillip H Kang, Virginia Lockatell, Nevins W Todd, John C Papadimitriou, Andrew N J McKenzie, Sergei P Atamas

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The IL-33/ST2 Axis Is Not Required for the Profibrotic Effect of IL-33 in the Lungs.American journal of respiratory cell and molecular biology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. IL-33 mediates Pseudomonas induced airway fibrogenesis and is associated with CLAD.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  13. Article
  14. The IL-33/ST2 Pathway in Cerebral Malaria.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  18. Article
  19. Article
  20. The Paradigm Change of IL-33 in Vascular Biology.International journal of molecular sciences · 2021
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Irina G LuzinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Edward M Pickering
Pavel Kopach
Phillip H Kang
Virginia Lockatell
Nevins W Todd
John C Papadimitriou
Andrew N J McKenzie
Sergei P Atamas
University of Maryland, Baltimore · USBaltimore VA Medical Center · USMedical Research Council · GBVeterans Health Administration · US

Funding

A Novel Model of, and Pre-clinical Therapy for, Scleroderma Lung DiseaseR21HL106196 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ATAMAS, SERGEI P. · 2011 to 2012
$422k
INTEGRIN-DEPENDENT T CELL-MEDIATED MECHANISMS OF PULMONARY FIBROSISR03AR054946 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2008 to 2010
$224k
Integrin-dependent mechanism of T cell-mediated pulmonary fibrosisI01CX000101 · VA · BALTIMORE VA MEDICAL CENTER · PI LUZINA, IRINA G. · 2009 to 2017
–
Unique immune regulation by alternatively spliced interleukin-4I01CX000107 · VA · BALTIMORE VA MEDICAL CENTER · PI ATAMAS, SERGEI P. · 2011 to 2014
–
CSRD VA I01 CX000101CSRD VA I01 CX000107Medical Research Council MC_U105178805NHLBI NIH HHS 1R21HL106196NHLBI NIH HHS R21 HL106196NIAMS NIH HHS 1R03AR054946NIAMS NIH HHS R03 AR054946
6 · The paper itself

Abstract

Expression of IL-33 is elevated in patients with pulmonary diseases, and full-length (not proteolytically processed) IL-33 is the predominant form in the lungs in health and disease. To determine whether activation of IL-33 is needed for functional effects, activities of full-length mouse and mature mouse (mm) forms of IL-33 were compared in vivo. Replication-deficient adenoviral constructs were used for gene delivery. Both isoforms caused pulmonary infiltration of lymphocytes and neutrophils, whereas mm IL-33 also caused pulmonary eosinophilia and goblet cell hyperplasia and increased expression of IL-4, IL-5, IL-13, IL-17, MCP-1, and KC. The different effects were not associated with differential release from IL-33-producing cells or by differences in subcellular distributions of IL-33 isoforms. Germline deficiency of the cell surface receptor chain ST2 abrogated the mm IL-33-induced Th2-associated effects (pulmonary eosinophilia, goblet cell hyperplasia, and increased IL-4 and IL-5), yet the lymphocytic infiltration induced by full-length mouse IL-33 or mm IL-33 was not fully abrogated by the absence of ST2. The similar effects of IL-33 isoforms were associated with comparable regulation of gene expression, notably matrix metalloproteinases 3, 10, and 13. Thus, full-length IL-33 is functionally active in vivo in an ST2-independent fashion, and its effects are partially different from those of mature IL-33. The different effects of these isoforms, particularly the pro-Th2 effects of mature IL-33, are due to differential utilization of the IL-33R chain ST2, whereas their similar effects result from regulation of gene expression.

Indexed as

AnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorFemaleGene Expression RegulationHEK293 CellsHumansInflammation MediatorsInterleukin-1 Receptor-Like 1 ProteinInterleukin-33InterleukinsLung NeoplasmsMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutIL1RL1 protein, humanIl1rl1 protein, mouseIL33 protein, humanIl33 protein, mouseInflammation MediatorsInterleukin-1 Receptor-Like 1 ProteinInterleukin-33InterleukinsReceptors, Cell SurfaceReceptors, Interleukin

Identifiers

PMID22634619
PMCPMC3381874
OpenAlexW2156087232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.